Daré Bioscience (DARE) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting of Stockholders scheduled for June 12, 2025, at 9:00 a.m. Pacific Time, to be held virtually.
Shareholders are encouraged to review proxy materials and vote by June 11, 2025.
Voting matters and shareholder proposals
Election of three Class II Directors: William H. Rastetter, Gregory W. Matz, and Robin J. Steele.
Ratification of Haskell & White, LLP as independent registered public accounting firm for fiscal 2025.
Advisory vote to approve named executive officer compensation.
Approval of amendment to the 2022 Stock Incentive Plan to increase shares by 600,000.
Provision to conduct any other business properly brought before the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director nominees and compensation matters.
Latest events from Daré Bioscience
- Annual meeting covers director elections, compensation, auditor, and share issuance proposals.DARE
Proxy filing28 Apr 2026 - Shareholders will vote on director elections, auditor ratification, compensation, and key capital proposals.DARE
Proxy filing28 Apr 2026 - Proxy covers director elections, auditor ratification, compensation, and key capital structure proposals.DARE
Proxy filing17 Apr 2026 - DARE to PLAY launched nationwide; new product revenues and pipeline milestones expected in 2026-2027.DARE
Q4 202527 Mar 2026 - Q2 net income hit $12.9M on royalty sale, but liquidity and future losses remain concerns.DARE
Q2 20241 Feb 2026 - Q3 net loss narrowed, major funding secured, but liquidity risks and capital needs persist.DARE
Q3 202413 Jan 2026 - Sildenafil cream to launch via 503B in Q4 2025; pipeline advances amid funding and enrollment shifts.DARE
Q4 202426 Dec 2025 - Shareholders will vote on director elections, auditor ratification, executive pay, and a stock plan amendment.DARE
Proxy Filing2 Dec 2025 - Annual meeting adjourned for lack of quorum; reconvenes July 9, 2025, with unchanged proposals.DARE
Proxy Filing2 Dec 2025